SPY330.06+1.27 0.39%
DIA268.41+1.69 0.63%
IXIC10,941.17+38.37 0.35%

UBS Maintains Neutral on Oragenics, Raises Price Target to $39

UBS maintains Oragenics (AMEX:OGEN) with a Neutral and raises the price target from $31 to $39.

Benzinga · -

UBS maintains Oragenics (AMEX:OGEN) with a Neutral and raises the price target from $31 to $39.